For example, Hobston et al. [4] found decreased visits to neurologists and other specialists, and suggested that as PwP age, medication regimes become simpler due to reduced tolerance, and care is transferred to non-specialists (i.e. FP) despite the increased complexity of PD/PKM care as the disease progresses. This evidence concerns the gene PKM and Parkinson disease.